2nd Quarter - Report
WILLIAMS AND JENSEN, PLLC for ABBOTT LABORATORIES
Client
Income
$50,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Financial Institutions/Investments/Securities FIN
Financial services
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL OSWALD | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax, including tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| KARINA LYNCH | — |
Health Issues HCR
Drug safety; Drug importation; authorized generics; drug company settlements; Preserve Access to Affordable Generics Act; Federal preemption for drugs and devices; Medical device safety; Prescription drug advertising; Congressional oversight issues; General health care reform (Patient Protection and Affordable Care Act). Reauthroization of the Prescription Drug User Fee Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| REBECCA ANDERSON New | White House Office of Legislative Affairs |
| JACK STEVEN HART | — |
| CHRISTOPHER W HATCHER | Sch. C, Treasury. ; LD, Rep. Scott McInnis |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
| JOEL OSWALD New | Prof. Staff, Senate Banking; LA, Sen. Enzi |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.